HRS 2024: Vektor Medical’s vMap Technology to be Highlighted in Rhythm Theater and Eight Posters
May 15 2024 - 7:33AM
Business Wire
Data Demonstrates vMap’s Ability to Locate
Arrhythmia Sources and Deliver Critical Value
Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia
analysis technology, today unveiled a comprehensive schedule of
educational content and sessions featuring the use of vMap® at this
year’s Heart Rhythm 2024 conference in Boston, May 16-19.
vMap rapidly provides actionable arrhythmia localization
insights for physicians. The research and presentations at HRS
further demonstrate the unique ability of vMap to assist physicians
with both focal and fibrillation-type arrhythmias. Attendees can
experience vMap at the Vektor Medical booth (#669), hear expert
perspectives from leading KOLs during the Rhythm Theater, and read
more about vMap in various scientific posters and presentations.
Details follow:
“The Future of Care: Leveraging AI for Arrhythmia
Localization” Rhythm Theater Symposium | Friday, May 17 |
4:00 – 5:00 p.m.
Discover how vMap integrates intelligently
into existing workflows, elevating patient care and streamlining
procedures. An expert panel including Drs. Gery Tomassoni, Ulrika
Birgersdotter-Green, Jag Singh, Ben D’Souza, John Miller, and David
Krummen will discuss the transformative power of AI-driven ECG
analysis, shaping the future of ablations, enhancing efficiencies,
and optimizing outcomes.
Scientific Posters and Abstract Presentations
Friday, May 17
- Outcomes of Non-Invasive Artificial Intelligence-based CT and
ECG Mapping to Guide Concomitant Surgical Ablation of Ventricular
Tachycardia at Time of LVAD Implantation PO-01-147 Lead Author: Gordon Ho, MD, et al. 10:30 a.m. –
12:30 p.m. | Abstract Pavilion - BCEC
- A Novel Machine Learning Algorithm Provides Greater Accuracy
than Visual ECG-based Criteria for Localizing Endocardial vs
Epicardial Activation of the Left Ventricle MP-470548-005
Presenting Author: Erin Dressens, DO
4:15 – 4:20 p.m. | Moderated Poster Hub 2 - BCEC
Saturday, May 18
- Forward Solution Machine Learning ECG Mapping to Guide Remote
Magnetic Navigation Catheter Ablation in a Patient with Polymorphic
Ventricular Tachycardia PO-04-197 Lead
Author: David E. Krummen, MD, et al. 10:30 a.m. – 12:30 p.m.
| Abstract Pavilion - BCEC
Sunday, May 19
- Non-Invasive Co-Localization of Ventricular Tachycardia
Isthmuses and Scar Using Integrated Artificial Intelligence-Based
CT and ECG Analysis PO-06-120 Lead
Author: Gordon Ho, MD, et al. 9:30 – 11:30 a.m. | Abstract
Pavilion - BCEC
- Clinical Outcomes of Prospective Computational 12-Lead ECG
Mapping Guided PVC Ablation PO-06-117 Lead
Author: Kevin Sung, MD, MS, et al. 9:30 – 11:30 a.m. |
Abstract Pavilion – BCEC
- Feasibility of Localizing the VT Isthmus Using AI-based CT and
ECG Mapping in the Presence of an LV Assist Device PO-06-199
Lead Author: Gordon Ho, MD, et al.
9:30 – 11:30 a.m. | Abstract Pavilion – BCEC
- Successful Stereotactic Radioablation of Calcified Epicardial
Ventricular Tachycardia Guided by Novel Non-Invasive Artificial
Intelligence-Based CT and 12-Lead ECG Mapping PO-06-196
Lead Author: Mitchell Wong, et al.
9:30 – 11:30 a.m. | Abstract Pavilion – BCEC
“HRS is a vital opportunity for us to connect with the
electrophysiology community, share our latest data, and receive
invaluable feedback,” said Rob Krummen, CEO of Vektor Medical. “Our
team is deeply committed to advancing cardiac care, and I’m excited
to see how vMap continues to improve patient outcomes and
streamline procedures. Our program of activities at HRS illustrates
the transformative power of vMap, both in tangible clinical results
and the broader, intangible benefits it brings to the healthcare
landscape.”
For more information about vMap or to meet with Vektor Medical
at HRS 2024, please visit booth 669, contact us here, and connect
on LinkedIn.
About vMap®
vMap is the only FDA-cleared, non-invasive AI-based solution for
mapping arrhythmias, utilizing just a 12-lead ECG. vMap localizes
arrhythmia sources for focal and fibrillation-type arrhythmias,
including atrial fibrillation. By unlocking actionable insights
contained within a standard 12-lead ECG, vMap enables physicians to
rapidly and accurately locate arrhythmia source locations. Backed
by extensive clinical evidence, vMap not only improves patient
outcomes but also reduces procedure time, optimizing workflow
across the entire arrhythmia care pathway.
About Vektor Medical
Headquartered in San Diego, Vektor Medical is on a mission to
revolutionize arrhythmia care for millions affected by atrial
fibrillation and other arrhythmias. Through its AI-based,
non-invasive arrhythmia analysis technology, vMap, the company aims
to improve cardiac ablation outcomes, optimize workflows, and
increase procedural efficiency. For more information about vMap and
Vektor Medical, please visit www.vektormedical.com.
Follow Vektor Medical: LinkedIn and Twitter/X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240515478951/en/
Media Contact Stacey Holifield Levitate (617) 233-3873
vektor@levitatenow.com